tirzepatide for heart failure with preserved ejection fraction and obesity Impact of Body Mass Index, Central Adiposity, Weight Loss on the Benefits of in HFpEF: The SUMMIT Trial VisualAbstract: Semaglutide in Patients with

Kami menyediakan berbagai pilihan perawatan yang menggunakan bahan-bahan berkualitas dan teknologi terkini untuk hasil optimal

Developed by Danish pharmaceutical company Novo Nordisk, it targets multiple parts of the brain's appetite control system, reducing hunger and cravings for food

The gastrointestinal symptoms result from tirzepatide's mechanism of slowing gastric emptying and are dose-dependent, which is why gradual dose escalation is recommended

This study proposes the use of poly(N-isopropylacrylamide) (PNIPAM) microgels for encapsulating methylene blue, an anticancer drug, for potential breast cancer treatment in the MCF-7 cell line